Can your genes make you more prone to pneumococcal disease?

References

• World Health Organization. Pneumococcal vaccines. Wkly Epidemiol. Rec.14, 110–119 (2003).
   Google Scholar
• British Thoracic Society Standards of Care Committee. BTS guidelines for the management of community-acquired pneumonia in adults. Thorax56(Suppl. IV), iv1–iv64 (2001).
   PubMedGoogle Scholar
• Bogaert D, de Groot R, Hermans PWM. Streptococcus pneumoniae colonisation: the key to pneumococcal disease. Lancet Infect. Dis.4, 144–154 (2004).
   PubMed Web of Science ®Google Scholar
• Musher DM. Streptococcus pneumoniae. In: Principles and Practice of Infectious Disease. Mandell GL, Bennett JE, Dolin R (Eds.). Churchill Livingstone, PA, USA, 2392–2411 (2004).
   Google Scholar
• Talbot TR, Hartert TV, Mitchel E et al. Asthma as a risk factor for invasive pneumococcal disease. N. Engl. J. Med.352, 2082–2090 (2005).
   PubMed Web of Science ®Google Scholar
• Parsons HK, Dockrell DH. The burden of invasive pneumococcal disease and the potential for reduction by immunisation. Int. J. Antimicrob. Agents19, 85–93 (2002).
   PubMed Web of Science ®Google Scholar
• Grant CC, Harnden AR, Jewell G, Knox K, Peto TE, Crook DW. Invasive pneumococcal disease in Oxford, 1985–2001: a retrospective case series. Arch. Dis. Child.88, 712–714 (2003).
   PubMedGoogle Scholar
• Cooke GC, Hill AVS. Genetics of susceptibility to human infectious disease. Nat. Rev. Genet.2, 967–977 (2001).
   PubMed Web of Science ®Google Scholar
• Weatherall DJ, Clegg JB. Genetic variability in response to infection: malaria and after. Genes Immun.3, 331–337 (2002).
   PubMedGoogle Scholar
• Sorensen TIA, Nielsen GG, Andersen PK, Teasdale TW. Genetic and environmental influences on premature death in adult adoptees. N. Engl. J. Med.318, 727–732 (1988).
   PubMed Web of Science ®Google Scholar
• Gingles NA, Alexander JE, Kadioglu A et al. Role of genetic resistance in invasive pneumococcal infection: identification and study of susceptibility and resistance in inbred mouse strains. Infect. Immun.69(1), 426–434 (2001).
   PubMed Web of Science ®Google Scholar
• Kerr AR, Irvine JJ, Search JJ et al. Role of inflammatory mediators in resistance and susceptibility to pneumococcal infection. Infect. Immun.70(3), 1547–1557 (2002).
   PubMedGoogle Scholar
• Brouwer MC, de Gans J, Heckenberg SG, Zwinderman AH, van der Poll T, van de Beek D. Host genetic susceptibility to pneumococcal and meningococcal disease: a systematic review and meta-analysis. Lancet Infect. Dis.9(1), 31–44 (2009).
   PubMed Web of Science ®Google Scholar
• Picard C, Puel A, Bustamante J, Ku C-L, Casanova J-L. Primary immunodeficiencies associated with pneumococcal disease. Curr. Opin. Allergy Clin. Immunol.3, 451–459 (2003).
   PubMed Web of Science ®Google Scholar
• Akira S, Takeda K. Toll-like receptor signalling. Nat. Rev. Immunol.4, 499–511 (2004).
   PubMed Web of Science ®Google Scholar
• Takeda K, Kaisho T, Akira S. Toll-like receptors. Annu. Rev. Immunol.21, 335–376 (2003).
   PubMed Web of Science ®Google Scholar
• Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, Golenbock D. Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol.163(1), 1–5 (1999).
   PubMed Web of Science ®Google Scholar
• Schroder NW, Morath S, Alexander C et al. Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved. J. Biol. Chem.278, 15587–15594 (2003).
   PubMed Web of Science ®Google Scholar
• Mogensen TH, Paludan SR, Kilian M, Ostergaard L. Live Streptococcus pneumoniae, Haemophilus influenzae, and Neisseria meningitides activate the inflammatory response through Toll-like receptors 2, 4, and 9 in species-specific patterns. J. Leukocyte Biol.80, 1–11 (2006).
   PubMedGoogle Scholar
• Letiembre M, Echchannaoui H, Bachmann P et al. Toll-like receptor 2 deficiency delays pneumococcal phagocytosis and impairs oxidative killing by granulocytes. Infect. Immun.73, 8397–8401 (2005).
   PubMedGoogle Scholar
• Malley R, Henneke P, Morse SC et al. Recognition of pneumolysin by Toll-like receptor 4 confers resistance to pneumococcal infection. Proc. Natl Acad. Sci.USA100(4), 1966–1971 (2003).
   PubMed Web of Science ®Google Scholar
• Spellerberg B, Rosenow C, Sha W, Tuomanen EI. Pneumococcal cell wall activates NF-κB in human monocytes: aspects distinct from endotoxin. Microb. Pathog.20, 309–317 (1996).
   PubMedGoogle Scholar
• Schmeck B, Zahlten J, Moog K et al.Streptococcus pneumoniae-induced p38 MAPK-dependent phosphorylation of RelA at the interleuin-8 promoter. J. Biol. Chem.279(51), 53241–53247 (2004).
   PubMed Web of Science ®Google Scholar
• Amory-Rivier CF, Mohler J, Bedos JP et al. Nuclear factor-κB activation in mouse lung lavage cells in response to Streptococcus pneumoniae pulmonary infection. Crit. Care Med.28(9), 3249–3256 (2000).
   PubMedGoogle Scholar
• Jones MR, Simms BT, Lupa MM, Kogan MS, Mizgerd JP. Lung NF-κB activation and neutrophils recruitment require IL-1 and TNF receptor signaling during pneumococcal pneumonia. J. Immunol.175, 7530–7535 (2005).
   PubMed Web of Science ®Google Scholar
• Quinton LJ, Jones MR, Simms BT et al. Functions and regulation of NF-κB RelA during pneumococcal pneumonia. J. Immunol.178, 1896–1903 (2007).
   PubMedGoogle Scholar
• von Bernuth H, Picard C, Jin Z et al. Pyogenic bacterial infections in humans with MyD88 deficiency. Science321(5889), 691–696 (2008).
   PubMed Web of Science ®Google Scholar
• Zonana J, Elder ME, Schneider LC et al. A novel X-linked disorder of immune deficiency and hypohidrotic ectodermal dysplasia is allelic to incontinentia pigmenti and due to mutations in IKK-g (NEMO). Am. J. Hum. Genet.67, 1555–1562 (2000).
   PubMed Web of Science ®Google Scholar
• Mansour S, Woffendin H, Mitton S et al. Incontinentia pigmenti in a surviving male is accompanied by hypohidrotic ectodermal dysplasia and recurrent infection. Am. J. Med. Genet.99, 172–177 (2001).
   PubMed Web of Science ®Google Scholar
• Doffinger R, Smahi A, Bessia C et al. X-linked anhidrotic ectodermal dysplasia with immunodeficiency is caused by impaired NF-κB signaling. Nat. Genet.27, 277–285 (2001).
   PubMed Web of Science ®Google Scholar
• Picard C, Puel A, Bonnet M et al. Pyogenic bacterial infections in humans with IRAK-4 deficiency. Science299, 2076–2079 (2003).
   PubMed Web of Science ®Google Scholar
• Courtois G, Smahi A, Reichenbach J et al. A hypermorphic IkBa mutation is associated with autosomal dominant anhidrotic ectodermal dysplasia and T cell immunodeficiency. J. Clin. Invest.112, 1108–1115 (2003).
   PubMed Web of Science ®Google Scholar
• Janssen R, van Wengen A, Hoeve MA et al. The same IkBa mutation in two related individuals leads to completely different clinical syndromes. J. Exp. Med.200, 559–568 (2004).
   PubMedGoogle Scholar
• Puel A, Picard C, Ku CL, Smahi A, Casanova JL. Inherited disorders of NF-κB-mediated immunity in man. Curr. Opin. Immunol.16, 34–41 (2004).
   PubMed Web of Science ®Google Scholar
• Medvedev AE, Lentschat A, Kuhns DB et al. Distinct mutations in IRAK-4 confer hyporesponsiveness to lipopolysaccharide and interleukin-1 in a patient with recurrent bacterial infections. J. Exp. Med.198, 521–531 (2003).
   PubMed Web of Science ®Google Scholar
• Chapman SJ, Khor CC, Vannberg FO et al. IkB genetic polymorphisms and invasive pneumococcal disease. Am. J. Respir. Crit. Care Med.176, 181–187 (2007).
   PubMed Web of Science ®Google Scholar
• Chapman SJ, Khor CC, Vannberg FO et al.NFKBIZ polymorphisms and susceptibility to pneumococcal disease in European and African populations. Genes Immun.11(4), 319–325 (2010).
   PubMedGoogle Scholar
• Abraham E. Alterations in cell signaling in sepsis. Clin. Infect. Dis.41, S459–S464 (2005).
   PubMed Web of Science ®Google Scholar
• Koedel U, Bayerlein I, Paul R, Sporer B, Pfister HW. Pharmacological interference with NF-κB activation attenuates central nervous system complications in experimental pneumococcal meningitis. J. Infect. Dis.182, 1437–1445 (2000).
   PubMed Web of Science ®Google Scholar
• Tak PP, Firestein GS. NF-κB: a key role in inflammatory diseases. J. Clin. Invest.107(1), 7–11 (2001).
   PubMed Web of Science ®Google Scholar
• Karin M, Yamamoto Y, Wang QM. The IKK NF-κB system: a treasure trove for drug development. Nat. Rev. Drug Discov.3, 17–26 (2003).
   Google Scholar
• Yamamoto M, Sato S, Hemmi H et al. Essential role for TIRAP in activation of the signalling cascade shared by TLR2 and TLR4. Nature420, 324–329 (2002).
   PubMed Web of Science ®Google Scholar
• Khor CC, Chapman SJ, Vannberg FO et al. A Mal functional variant is associated with protection against invasive pneumococcal disease, bacteremia, malaria and tuberculosis. Nat. Genet.39(4), 523–528 (2007).
   PubMed Web of Science ®Google Scholar
• Ferwerda B, Alonso S, Banahan K et al. Functional and genetic evidence that the Mal/TIRAP allele variant 180L has been selected by providing protection against septic shock. Proc. Natl Acad. Sci. USA106(25), 10272–10277 (2009).
   PubMedGoogle Scholar
• Miller LH, Baruch DI, Marsh K, Doumbo OK. The pathogenic basis of malaria. Nature415, 673–679 (2002).
   PubMed Web of Science ®Google Scholar
• Annane D, Bellissant E, Cavaillon JM. Septic shock. Lancet365(9453), 63–78 (2005).
   PubMed Web of Science ®Google Scholar
• Cundell DR, Gerard NP, Gerard C, Idanpaan-Heikkila I, Tuomanen EI. Streptococcus pneumoniae anchor to activated human cells by the receptor for platelet-activating factor. Nature377, 435–438 (1995).
   PubMed Web of Science ®Google Scholar
• Eisen DP, Minchinton RM. Impact of mannose-binding lectin on susceptibility to infectious diseases. Clin. Infect. Dis.37, 1496–1505 (2003).
   PubMed Web of Science ®Google Scholar
• Mullighan CG, Heatley S, Doherty K et al. Mannose-binding lectin gene polymorphisms are associated with major infection following allogeneic hemopoietic stem cell transplantation. Blood99, 3524–3529 (2002).
   PubMed Web of Science ®Google Scholar
• Kilpatrick DC. Mannan-binding lectin: clinical significance and applications. Biochim. Biophys. Acta1572, 401–413 (2002).
   PubMed Web of Science ®Google Scholar
• Summerfield JA, Sumiya M, Levin M et al. Association of mutations in mannose binding protein gene with childhood infection in consecutive hospital series. Br. Med. J.314, 1229–1232 (1997).
   PubMed Web of Science ®Google Scholar
• Roy S, Knox K, Segal S et al. MBL genotype and risk of invasive pneumococcal disease: a case–control study. Lancet359, 1569–1573 (2002).
   PubMed Web of Science ®Google Scholar
• Kronborg G, Garred P. Mannose-binding lectin genotype as a risk factor for invasive pneumococcal infection. Lancet360, 1176 (2002).
   PubMedGoogle Scholar
• Hibberd ML, Sumiya M, Summerfield JA et al. Association of variants of the gene for mannose-binding lectin with susceptibility to meningococcal disease. Lancet353, 1049–1053 (1999).
   PubMed Web of Science ®Google Scholar
• Koch A, Melbye M, Sorensen P et al. Acute respiratory tract infections and mannose-binding lectin insufficiency during early childhood. JAMA285, 1316–1321 (2001).
   PubMed Web of Science ®Google Scholar
• Garred P, Strom JJ, Quist L et al. Association of mannose-binding lectin polymorphisms with sepsis and fatal outcome, in patients with systemic inflammatory response syndrome. J. Infect. Dis.188, 1394–1403 (2003).
   PubMed Web of Science ®Google Scholar
• Peterslund NA, Koch C, Jensenius JC et al. Association between deficiency of mannose-binding lectin and severe infections after chemotherapy. Lancet358, 636–638 (2001).
   PubMedGoogle Scholar
• Neth O, Hann I, Turner MW et al. Deficiency of mannose-binding lectin and burden of infection in children with malignancy: a prospective study. Lancet358, 614–618 (2001).
   PubMed Web of Science ®Google Scholar
• Garcia-Laorden MI, Sole-Violan J, Rodriguez de Castro F et al. Mannose-binding lectin and mannose-binding lectin-associated serine protease 2 in susceptibility, severity, and outcome of pneumonia in adults. J. Allergy Clin. Immunol.122(2), 368–374 (2008).
   PubMedGoogle Scholar
• Endeman H, Herpers BL, de Jong BA et al. Mannose-binding lectin genotypes in susceptibility to community acquired pneumonia. Chest134(6), 1135–1140 (2008).
   PubMedGoogle Scholar
• Rantala A, Lajunen T, Juvonen R et al. Mannose-binding lectin concentrations, MBL2 polymorphisms, and susceptibility to respiratory tract infections in young men. J. Infect. Dis.198(8), 1247–1253 (2008).
   PubMed Web of Science ®Google Scholar
• Eisen DP, Dean MM, Boermeester MA et al. Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection. Clin. Infect. Dis.47(4), 510–516 (2008).
   PubMed Web of Science ®Google Scholar
• Stengaard-Pedersen K, Thiel S, Gadjeva M et al. Inherited deficiency of mannan-binding lectin-associated serine protease 2. N. Engl. J. Med.349, 554–560 (2003).
   PubMedGoogle Scholar
• Bottini N, Musumeci L, Alonso A et al. A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes. Nat. Genet.36, 337–338 (2004).
   PubMed Web of Science ®Google Scholar
• Gregersen PK, Lee HS, Batliwalla F, Begovich AB. PTPN22: setting thresholds for autoimmunity. Sem. Immunol.18, 214–223 (2006).
   PubMed Web of Science ®Google Scholar
• Begovich AB, Carlton VE, Honigberg LA et al. A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis. Am. J. Hum. Genet.75, 330–337 (2004).
   PubMed Web of Science ®Google Scholar
• Kyogoku C, Langefeld CD, Ortmann WA et al. Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE. Am. J. Hum. Genet.75, 504–507 (2004).
   PubMed Web of Science ®Google Scholar
• Carlton VEH, Hu X, Chokkalingam AP et al.PTPN22 genetic variation: evidence for multiple variants associated with rheumatoid arthritis. Am. J. Hum. Genet.77, 567–581 (2005).
   PubMed Web of Science ®Google Scholar
• Smyth D, Cooper JD, Collins JE et al. Replication of an association between the lymphoid tyrosine phosphatase locus (LYP/PTPN22) with type 1 diabetes, and evidence for its role as a general autoimmunity locus. Diabetes53, 3020–3023 (2004).
   PubMed Web of Science ®Google Scholar
• Velaga MR, Wilson V, Jennings CE et al. The codon 620 tryptophan allele of the lymphoid tyrosine phosphatase (LYP) gene is a major determinant of Graves’ disease. J. Clin. End. Met.89, 5862–5865 (2004).
   PubMed Web of Science ®Google Scholar
• Canton I, Akhtar S, Gavalas NG et al. A single-nucleotide polymorphism in the gene encoding lymphoid protein tyrosine phosphatase (PTPN22) confers susceptibility to generalised vitiligo. Genes Immun.6, 584–587 (2005).
   PubMed Web of Science ®Google Scholar
• Michou L, Lasbleiz S, Rat AC et al. Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene. Proc. Natl Acad. Sci. USA104, 1649–1654 (2007).
   PubMed Web of Science ®Google Scholar
• Siminovitch KA. PTPN22 and autoimmune disease. Nat. Genet.36, 1248–1249 (2004).
   PubMed Web of Science ®Google Scholar
• Wellcome Trust Case Control Consortium. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls. Nature447, 661–678 (2007).
   PubMed Web of Science ®Google Scholar
• Bottini N, Vang T, Cucca F, Mustelin T. Role of PTPN22 in type 1 diabetes and other autoimmune diseases. Sem. Immunol.18, 207–213 (2006).
   PubMed Web of Science ®Google Scholar
• Gregersen PK. Gaining insight into PTPN22 and autoimmunity. Nat. Genet.37, 1300–1302 (2005).
   PubMed Web of Science ®Google Scholar
• Vang T, Congia M, Macis MD et al. Autoimmune-associated lymphoid tyrosine phosphatase is a gain-of-function variant. Nat. Genet.37, 1317–1319 (2005).
   PubMed Web of Science ®Google Scholar
• Arechiga AF, Habib T, He Y et al. Cutting edge: the PTPN22 allelic variant associated with autoimmunity impairs B cell signaling. J. Immunol.182(6), 3343–3347 (2009).
   PubMed Web of Science ®Google Scholar
• Chapman SJ, Khor CC, Vannberg FO et al.PTPN22 and invasive bacterial disease. Nat. Genet.38(5), 499–500 (2006).
   PubMed Web of Science ®Google Scholar
• Barreiro LB, Quintana-Murci L. From evolutionary genetics to human immunology: how selection shapes host defence genes. Nat. Rev. Genet.11(1), 17–30 (2010).
   PubMed Web of Science ®Google Scholar
• McCarthy MI, Abecasis GR, Cardon LR et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat. Rev. Genet.9(5), 356–369 (2008).
   PubMed Web of Science ®Google Scholar
• Bodmer W, Bonilla C. Common and rare variants in multifactorial susceptibility to common diseases. Nat. Genet.40(6), 695–701 (2008).
   PubMed Web of Science ®Google Scholar
• Casanova JL, Abel L. Primary immunodeficiencies: a field in its infancy. Science317(5838), 617–619 (2007).
   PubMed Web of Science ®Google Scholar